My understanding is that the cardiologists understand that it is their role to identify risk factors that can be intervened to improve the patient’s heart disease. REDLINE: That is a fantastic question, the impression and of course, I think it’s an evolving landscape. So, is your impression that this would be sort of under the umbrella of the cardiology program or is this in collaboration with sleep medicine? KHOSLA: So, the message to me seems to be that cardiology should be more intentional about screening for OSA in their patients. And it was all those areas that were addressed in that recent American Heart Association statement. And also overviews and statements regarding the role of screening and treatment. And in that way, they have interest, they are very committed to publishing state of the art reviews, reviewing the biologic, physiologic links between sleep apnea and a variety of heart disease, as well as providing overviews of what the spectrum of diagnostic and screening modalities are. REDLINE: The American Heart Association has shown a specific level of interest and commitment to educate their members, that is, our colleagues in cardiology, on the links between sleep apnea and heart disease. So, you were part of a paper published by the AHA that talked about the importance of screening for OSA and cardiology patients. KHOSLA: They’re actually really toned down from my first draft. I hope I could live up to some of those comments during the next few minutes. REDLINE: Well, thank you for the invitation and thank you for that awfully generous and kind comments. She’ll be the keynote speaker at SLEEP 2022 and recently was part of a paper from the American Heart Association on screening for obstructive sleep apnea in cardiovascular patients. She has harnessed big data and looks at environmental and socio-economic issues related to sleep apnea and works to address sleep health disparities. Redline is a legend in our field and has managed not only to further sleep research but has extensively evaluated how sleep intersects with other disorders. She directs programs in sleep and cardiovascular medicine and sleep medicine epidemiology at Brigham and Women’s Hospital and Beth Israel Deaconess Medical Center. Redline is a professor of sleep medicine and professor of epidemiology at Harvard. It’s my honor to kick off the new year with a very special guest, Dr. Seema Khosla, medical director of the North Dakota Center for Sleep in Fargo. A podcast of the American Academy of Sleep Medicine. KHOSLA: Thank you for joining us for Talking Sleep. She has co-authored more than 600 manuscripts and is a past board member of the AASM and the Sleep Research Society. She founded and co-directs the National Sleep Research Resource, an international sleep data sharing repository that has focused on making research data easily searchable and accessible, supporting community access to data and a suite of open-source signal processing, visualization, and data exploration tools. She leads the Sleep Reading Center for a number of major NIH multicenter studies has led large cohort studies investigating cardiovascular and neurocognitive outcomes of sleep disorders and leads several large randomized controlled trials. Redline’s research includes epidemiological studies and clinical trials designed to elucidate the etiologies of sleep disorders, including the role of genetic and early life developmental factors and understand the cardiovascular and other health outcomes of sleep disorders and the role of sleep interventions in improving health. Farrell professor of sleep medicine at Harvard Medical School, professor of epidemiology at Harvard TH Chan School of Public Health, and director of the programs in sleep and cardiovascular medicine and sleep medicine epidemiology at Brigham and Women’s Hospital. Guiding Principles for Industry Support.Young Investigators Research Forum (YIRF).
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |